Soc. Generale Call 44 FPE3 21.06..../ DE000SU10KT3 /
31/05/2024 21:36:08 | Chg.0.000 | Bid21:51:33 | Demandez à21:51:33 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
0.120EUR | 0.00% | 0.130 Bid taille: 10,000 |
0.150 Ask la taille: 10,000 |
FUCHS SE VZO NA O.N... | 44.00 EUR | 21/06/2024 | Call |
GlobeNewswire
01:00
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
02/06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02/06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02/06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire
02/06
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
GlobeNewswire
02/06
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
02/06
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...
GlobeNewswire
02/06
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page